论文信息 - Tissue Plasminogen Activator in Critically Ill Adults with COVID-19 - 字舞流文

Tissue Plasminogen Activator in Critically Ill Adults with COVID-19

D. Leaf | K. Mathews | Shruti Gupta | S. Shaefi | D. Douin | F. Wright | H. Al‐Samkari | L. Chan | J. Radbel | S. K. Brenner | S. Orfanos | I. Park

[1] A. Sauaia,et al. Study of alteplase for respiratory failure in severe acute respiratory syndrome coronavirus 2/COVID‐19: Study design of the phase IIa STARS trial , 2020, Research and Practice in Thrombosis and Haemostasis.

[2] G. Grasselli,et al. Hypercoagulability of COVID‐19 patients in intensive care unit: A report of thromboelastography findings and other parameters of hemostasis , 2020, Journal of Thrombosis and Haemostasis.

[3] J. Burke,et al. Fibrinolytic therapy for refractory COVID‐19 acute respiratory distress syndrome: Scientific rationale and review , 2020, Research and Practice in Thrombosis and Haemostasis.

[4] Y. Naka,et al. Prognostic value of vasoactive-inotropic score following continuous flow left ventricular assist device implantation. , 2019, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[5] J. Giri,et al. Thrombolysis for pulmonary embolism and risk of all-cause mortality, major bleeding, and intracranial hemorrhage: a meta-analysis. , 2014, JAMA.